BioSymetrics vs Immunai
BioSymetrics vs Immunai, compared side by side on 18 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: BioSymetrics is on 63/100 and Immunai on 69/100.
Where each one leads
BioSymetrics
- agent readiness: 46/100 against 32/100
- headcount growth: +139.3% against +13.0%
Immunai
- our overall score: 69/100 against 63/100
- domain rating: 46/100 against 30/100
- headcount: 179 against 14
- funding raised: $295M against $6.6M
- LinkedIn following: 26,832 against 3,571
At a glance
| Measure | BioSymetrics | Immunai |
|---|---|---|
| What it is | Phenomics-driven AI company translating disease biology into precision medicine discoveries. | Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery. |
| Category | Biotech, HealthTech, Drug Discovery, Genomics | Healthcare, Immunology, Data, Analytics |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Software |
| Founded | 2017 | 2019 |
| Headquarters | Boston, United States | New York, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | BioSymetrics | Immunai |
|---|---|---|
| Employees | 14 | 179 |
| Headcount growthLast 12 months | +139.3% | +13.0% |
| Total funding | $6.6M | $295M |
| Latest round | Seed | Series B |
| Valuation | Not published | $1.0B |
| LinkedIn followers | 3,571 | 26,832 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | BioSymetrics | Immunai |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 63/100 | 69/100 |
| Traction | Not published | 60/100 |
| Team | 96/100 | 70/100 |
| Search visibility | 64/100 | 39/100 |
| Quality | Not published | 78/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (46/100) | F (32/100) |
| Domain ratingLink authority, 0-100 | 30/100 | 46/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | BioSymetrics | Immunai |
|---|---|---|
| CMS | Not detected | WordPress |
| Frameworks | Not detected | Jquery, Bootstrap |
| Analytics | Not detected | Google Tag Manager |
| Open source | Yes | No |
BioSymetrics vs Immunai: common questions
Which is better, BioSymetrics or Immunai?
On our 0-100 score Immunai rates higher (69/100 against 63/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 18 data points above: read the rows that match what you are buying for.
How do BioSymetrics and Immunai compare on the numbers?
BioSymetrics leads on agent readiness (46/100 against 32/100), headcount growth (+139.3% against +13.0%). Immunai leads on our overall score (69/100 against 63/100), domain rating (46/100 against 30/100), headcount (179 against 14), funding raised ($295M against $6.6M), LinkedIn following (26,832 against 3,571).
Read the full BioSymetrics review and pricing or the Immunai review and pricing. You can also browse other BioSymetrics alternatives we track.